POWER
Research type
Research Study
Full title
Prospective study to assess, Outcomes and healthcare resource use of current standard of care for patients With moderate and sEvere MDD Requiring urgent symptom control in a psychiatric emergency: POWER
IRAS ID
273050
Contact name
Damien Longson
Contact email
Sponsor organisation
Janssen Cilag Ltd
Duration of Study in the UK
2 years, 2 months, 30 days
Research summary
The aims of the study are to collect information on the treatment approaches currently used in the NHS for patients with symptoms of major depressive disorder (MDD) that have current suicidal ideation with intent.
As such, the study sample will include patients receiving care in either an inpatient (psychiatric ward) or community (at home) setting under an NHS mental health Trust
If the patient has a friend, relative or neighbour that provides regular unpaid support (i.e. an informal carer) this person will also be asked if they would like to take part in the study, but only if the patient agrees to this.The study procedures are as follows:
A member of the research team at the NHS mental health Trust will look at patients’ medical records to gather information on the treatment they received, for example – number of appointments, type of medication. Secondly, the researchers will ask a set of questions at 5 time points over 90 days. The questions will be about symptoms, thoughts and feelings.
Carers will also be asked a separate set of questions, but at 4 time points over 90 days. The questions will be about their health, well-being and work productivity.The information gathered in this study will help provide an understand of how high risk patients with severe depression are treated and the impact this has on them and their carers.
REC name
London - Brighton & Sussex Research Ethics Committee
REC reference
20/PR/0186
Date of REC Opinion
26 Nov 2020
REC opinion
Further Information Favourable Opinion